Category Archives: Monoclonal antibodies

Ustekinumab for plaque psoriasis approved by FDA

FDA approved ustekinumab (Stelara) for plaque psoriasis. Here, a quick overview:

In the last few years biologic therapy has shown promise in the treatment of psoriasis. Many TNF blockers (adalimumab, etanercept, infliximab) are now indicated in severe cases that do not respond to other therapies.

On September 25, 2009 the U.S. FDA approved ustekinumab (Stelara, manufactured by Centocor Ortho Biotech Inc, a subsidiary of Johnson & Johnson) for the treatment of plaque psoriasis.

Ustekinumab is a monoclonal antibody that targets IL-12 and IL-23,  and it is administered by subcutaneous route.

The UK’s National Institute for Health and Clinical Excellence issued a guidance that recommended ustekinumab use in the following clinical setting:

Severe psoriasis that has not responded to standard systemyc therapies including ciclosporin, methotrexate and PUVA(psoralen and long-wave ultraviolet radiation). Ustekinumab (Stelara), may also be considered in patients intolerant or have a contraindication to these treatments.

Ustekinumab (Stelara) mechanism of action in psoriasis

ustekinumab

.

.

The figure shows how ustekinumab (CNTO) blocks interleukin 12 (IL-12) and interleukin 23 (IL-23), these cytokines are involved in T-cell activation and promote immune response.

.

.

.

.

Further reading

Efficacy and safety of ustekinumab in patients with psoriasis: PHOENIX 1 and PHOENIX 2 trials. National electronic Library for Medicines, NHS.

Review: Treatments for psoriasis and risk of malignancy. National electronic Library for Medicines, NHS.


Video lecture: Biologic therapies for inflammatory and autoimmune diseases

Dr. Chan explains how biologic therapy (mainly through monoclonal antibodies) is changing the present and future of autoimmune and inflammatory diseases. He illustrates some examples of autoimmune diseases such as: multiple sclerosis, asthma, treatment of rheumatoid arthritis with etanercept, and others.Continue Reading

Overview on monoclonal antibody therapy: PPT, images and videos

This post intends to be a brief and readable overview on what monoclonal antibodies (mAbs) are and some examples of their clinical applications. The following slideshow is a clear and accurate introduction on the topic: (ignore the first slide error message and move to the second)Continue Reading

Are you a visual learner interested in learning psychopharmacology? Click here to get our videos